Effect of meloxicam or robenacoxib administration timing on renal function and postoperative analgesia in cats undergoing ovariohysterectomy: A randomized, blinded, controlled clinical trial
Journal of Veterinary Pharmacology and Therapeutics · 2024-05 · 47 (3) · 175-186
DOI: 10.1111/jvp.13427 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Veterinary Pharmacology and Therapeutics, online erschienen am 18.01.2024. Verfasst von Alex Krekis und 5 weiteren Autor:innen. Beteiligte Einrichtung: Davies Veterinary Specialists, Hitchin, UK. Hauptthemen laut MEDLINE: Diphenylamine, Hysterectomy, Meloxicam, Ovariectomy. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Novartis Animal Health.
Abstract (Originalsprache)
We evaluated the effect of administration timing of meloxicam and robenacoxib on renal function, platelet cyclo‐oxygenase and perioperative analgesia in 60 cats undergoing ovariohysterectomy, in a prospective randomized blinded controlled study. Twelve cats were randomly allocated to one subcutaneous treatment group: meloxicam (0.2 mg/kg) or robenacoxib (2 mg/kg) at admission (MA, RA), at induction (MI, RI) and robenacoxib at the end of surgery (RE). All cats received the same anaesthesia protocol. Plasma renin activity (PRA), plasma creatinine, drug concentrations and serum thromboxane (TxB 2 ) were measured sequentially. Anaesthesia significantly increased PRA, as activity at end of the surgery was higher than 2 h later (mean ± SD: 26.6 ± 2.8 versus 10.0 ± 3.9 ng/mL/h). PRA remained higher at 2 h post‐surgery in admission groups compared to induction groups ( p = .01). Serum TxB 2 was lower with meloxicam than robenacoxib ( p = .001), and was lower in the MA than each robenacoxib group at catheter placement. Admission groups (16/24 from RA and MA groups) received earlier rescue analgesia than other groups ( p = .033). In conclusion, the renin‐angiotensin system was activated during anaesthesia despite cyclo‐oxygenase inhibition, possibly due to hypotension or surgical stimulation. There was no effect of drug or timing on the markers of renal function but one cat receiving meloxicam at induction had suspected IRIS grade II acute kidney injury.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Davies Veterinary Specialists, Hitchin, UK.
- J.N.King Consulting, Bennwil, Switzerland.
- Department of Clinical Science and Services, Beaumont Sainsbury Animal Hospital, Royal Veterinary College, University of London, London, UK.
- Department of Comparative Biomedical Sciences, Royal Veterinary College, University of London, London, UK.
- Department of Clinical Science and Services, Queen Mother Hospital for Animals, Royal Veterinary College, University of London, London, UK.
ORCID-Profile: Alex Krekis, Jonathan Elliott, Ludovic Pelligand
Förderung
- Novartis Animal Health
Zitieren
APA
Krekis, A., King, J. N., D'Arcy-Howard, D., Stapleton, N., Elliott, J., & Pelligand, L. (2024). Effect of meloxicam or robenacoxib administration timing on renal function and postoperative analgesia in cats undergoing ovariohysterectomy: A randomized, blinded, controlled clinical trial. Journal of Veterinary Pharmacology and Therapeutics, 47(3), 175-186. https://doi.org/10.1111/jvp.13427
Vancouver
Krekis A, King JN, D'Arcy-Howard D, Stapleton N, Elliott J, Pelligand L. Effect of meloxicam or robenacoxib administration timing on renal function and postoperative analgesia in cats undergoing ovariohysterectomy: A randomized, blinded, controlled clinical trial. Journal of Veterinary Pharmacology and Therapeutics. 2024;47(3):175-186. doi:10.1111/jvp.13427
BibTeX
@article{Krekis2024,
author = {Krekis, Alex and King, Jonathan N and D'Arcy-Howard, Duncan and Stapleton, Nadene and Elliott, Jonathan and Pelligand, Ludovic},
title = {Effect of meloxicam or robenacoxib administration timing on renal function and postoperative analgesia in cats undergoing ovariohysterectomy: A randomized, blinded, controlled clinical trial},
journal = {Journal of Veterinary Pharmacology and Therapeutics},
year = {2024},
volume = {47},
number = {3},
pages = {175--186},
doi = {10.1111/jvp.13427}
}
EUVIMED